Quest Laboratories Ltd.(NSE:QUESTLAB)

Quest Laboratories Ltd. is engaged in the business of manufacturing pharmaceutical formulations. It offers antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments and antidepressants. The firm's products include: Chlorpheniramine Maleate Tablets IP 4 mg, Metformin Hydrochloride Tablets IP 500 mg, Metronidazole Tablets IP 200 mg, Dicyclomine Hydrochloride Tablets IP 10 mg, Metformin Hydrochloride Tablets IP 500 mg, Ibuprofen Tablets Br 400 mg BRUPAIN, Paracetamol & Dicyclomine Hydrochloride Tablets, liquid orals, Cyproheptadine Hydrochloride & Tricholine Citrate Syrup, Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup, Cypronex-T Syrup, ointments and suspension prodcuts. The company was founded on June 1, 1998 and is headquartered in Dhar, India.